Chinese Journal of Pharmacovigilance ›› 2016, Vol. 13 ›› Issue (4): 223-225.
Previous Articles Next Articles
ZHANG Qiu
Received:
2015-12-01
Revised:
2016-06-30
Online:
2016-04-20
Published:
2016-06-30
CLC Number:
ZHANG Qiu. Study on Group Adverse Drug Events Emergency Exercises[J]. Chinese Journal of Pharmacovigilance, 2016, 13(4): 223-225.
[1] 原国家食品药品监督管理局.药品和医疗器械安全突发事件应急预案(试行)国食药监办[2011]370号[S].(2011-08-03)[2016-01-15].http://www.sad.gov.cn/WS01/CL0001. [2] 国务院应急管理办公室.突发事件应急演练指南——国务院应急管理办公室应急办函[2009]62号[S].(2009-02-05)[2016-01-15].http://wenku.baidu.com/link?url=VCxLCptQY3OAr-IQegJRlTwMbvzbZXCMItlJiGBL_HOwXApjyGqIck6sd8oR59HlZjzB1mxGKoZ80USpqcXOLeRSNIq16GVEHuewWLgQ0rO. [3] 李亦纲,尹光辉,黄建发,等.应急演练中的几个关键问题[J].中国应急救援,2007,5:33-35. [4] 姜传胜,邓云峰,贾海江,等.突发事件应急演练的理论思辨与实践探索[J].中国安全科学学报,2011,21(6):153-159. [5] 李雪峰. 应急管理演练式培训[M].北京:国家行政学院出版社,2013:55-57. [6] 袁振龙,左袖阳.全媒体时代突发事件舆论引导的策略选择[J].社会主义研究,2013,2:123-128. [7] 原中华人民共和国卫生部. 药品不良反应报告和监测管理办法(卫生部令第81号)[S]. (2011-05-04)[2016-01-22].http://www.sda.gov.cn/WS01/CL0053/62621.html. [8] 夏保成,张小兵,王慧彦.突发事件应急演习与演习设计[M].北京:当代中国出版社,2011:99-103. [9] 戴秋萍,董耿,杨悦,等.我国药品不良反应事件处理现状调研及对策[J].中国药房,2010,10(10):64-44. [10] 洪凯,陈绮桦.美国应急演练体系的发展与启示[J].中国应急管理,2011,9:54-59. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||